Grace Therapeutics GRCE
NASDAQ GRCE
$1.97 -0.01 (-0.51%)
At close: Oct 21, 2026 · 4:00 PM EDT

Grace Therapeutics (GRCE) EBIT Margin (2020 - 2026)

Updated

Grace Therapeutics' EBIT Margin was -2000.00% in fiscal Q4 2021 (quarter ended Mar 31, 2021), up 424.69 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) EBIT Margin (2020 - 2026) Analysis & Trends

For FY2021 (ended Mar 31, 2021), EBIT Margin at Grace Therapeutics came in at -8377.04%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 28.21%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 37.86%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -3.52%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 32.97%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 20.57%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 34.95%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -133.21%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 28.37%
10 Grace Therapeutics 34.02 Mn -32.25 Mn - -11,288.65%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11,288.65%
Mar 31, 2026 -2,181.16%
Dec 31, 2025 -1,423.84%
Sep 30, 2025 -1,470.35%
Jun 30, 2025 -1,514.71%
Mar 31, 2025 -1,729.89%
Dec 31, 2024 -2,916.54%
Sep 30, 2024 -2,654.40%
Jun 30, 2024 -2,111.91%
Mar 31, 2021 -2,000.00%
Dec 31, 2020 -2,424.69%
API Access

Grace Therapeutics EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=GRCE&period=max&api_key=YOUR_API_KEY